| 000 | 01595 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514071505.0 | ||
| 264 | 0 | _c20030808 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/s0145-2126(02)00347-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaydam, Guray | |
| 245 | 0 | 0 |
_aInvolvement of protein phosphatase 2A in interferon-alpha-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells. _h[electronic resource] |
| 260 |
_bLeukemia research _cAug 2003 |
||
| 300 |
_a709-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aPhosphoprotein Phosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProtein Phosphatase 2 |
| 650 | 0 | 4 |
_aProtein Subunits _xanalysis |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aAydin, Hikmet Hakan | |
| 700 | 1 | _aSahin, Fahri | |
| 700 | 1 | _aSelvi, Nur | |
| 700 | 1 | _aOktem, Gulperi | |
| 700 | 1 | _aTerzioglu, Ender | |
| 700 | 1 | _aBuyukkececi, Filiz | |
| 700 | 1 | _aOmay, Serdar Bedii | |
| 773 | 0 |
_tLeukemia research _gvol. 27 _gno. 8 _gp. 709-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0145-2126(02)00347-8 _zAvailable from publisher's website |
| 999 |
_c12586004 _d12586004 |
||